Second‐line immunotherapy in new onset refractory status epilepticus
Several pieces of evidence suggest immune dysregulation could trigger the onset and
modulate sequelae of new onset refractory status epilepticus (NORSE), including its subtype …
modulate sequelae of new onset refractory status epilepticus (NORSE), including its subtype …
Identification of 3 key genes as novel diagnostic and therapeutic targets for OA and COVID-19
Y Zhang, Z Duan, Y Guan, T Xu, Y Fu, G Li - Frontiers in Immunology, 2023 - frontiersin.org
Background Corona Virus Disease 2019 (COVID-19) and Osteoarthritis (OA) are diseases
that seriously affect the physical and mental health and life quality of patients, particularly …
that seriously affect the physical and mental health and life quality of patients, particularly …
Intravenous high-dose anakinra drops venous thrombosis and acute coronary syndrome in severe and critical COVID-19 patients: a propensity score matched study
In our study, we aimed to evaluate the effect of high-dose intravenous anakinra treatment on
the development of thrombotic events in severe and critical COVID-19 patients. This …
the development of thrombotic events in severe and critical COVID-19 patients. This …
Combination therapy of high-dose intravenous anakinra and baricitinib in patients with critical COVID-19: Promising results from retrospective observational study
Introduction In this study, we aimed to evaluate the safety and efficacy of combination
treatment of high-dose intravenous anakinra and baricitinib in patients with critically ill …
treatment of high-dose intravenous anakinra and baricitinib in patients with critically ill …
[HTML][HTML] Individualized High Dose Intravenous Anakinra Treatment in Cancer Patients with COVID-19 Associated Cytokine Storm: A Retrospective Controlled Study
R Çakmak, M Bektaş - Infectious Diseases & Clinical Microbiology, 2024 - ncbi.nlm.nih.gov
Objective Patients with COVID-19 accompanying cancer have been reported to have higher
morbidity and mortality. In this study, we aimed to evaluate the high-dose high intravenous …
morbidity and mortality. In this study, we aimed to evaluate the high-dose high intravenous …
[PDF][PDF] Intravenous High-dose Anakinra Drops Venous Thrombosis and Myocardial Infarction in Severe and Critical COVID-19 Patients: A Propensity Score Matched …
Introduction: In our study, we aimed to evaluate the effect of high dose intravenous anakinra
treatment on development of thrombotic events in severe and critical COVID-19 patients …
treatment on development of thrombotic events in severe and critical COVID-19 patients …
Evaluation of Predictors Associated with COVID-19 Pneumonia in Rheumatic Patients Using Biological or Targeted Therapies: Results from a Tertiary Center in …
Aim: Disease-related immune dysfunction and/or treatment with immunosuppressive drugs
may affect the course of coronavirus disease-2019 (COVID-19) infection in rheumatic …
may affect the course of coronavirus disease-2019 (COVID-19) infection in rheumatic …
Anakinra for the prophylaxis of venous thromboembolism in patients with COVID-19
Bektaş et al.(2023), in a retrospective observational study, investigated the effect of high-
dose intravenous anakinra on the clinical outcomes in patients with severe and critically ill …
dose intravenous anakinra on the clinical outcomes in patients with severe and critically ill …